Pacific Biosciences of California, Inc. (PACB) News
Filter PACB News Items
PACB News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
PACB News Highlights
- For PACB, its 30 day story count is now at 9.
- Over the past 21 days, the trend for PACB's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- The most mentioned tickers in articles about PACB are CVRX, GENE and ROKU.
Latest PACB News From Around the Web
Below are the latest news stories about PACIFIC BIOSCIENCES OF CALIFORNIA INC that investors may wish to consider to help them evaluate PACB as an investment opportunity.
PacBio to Present at 42nd Annual J.P. Morgan Healthcare ConferencePacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be presenting at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 1:30 PM PT (4:30 PM ET) in San Francisco, California. |
CVRx (CVRX) Moves 24.2% Higher: Will This Strength Last?CVRx (CVRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term. |
Reasons to Retain PacBio (PACB) Stock in Your Portfolio NowPacBio's (PACB) product development activities raise optimism about the stock. |
12 Most Promising Gene Editing Stocks According to Hedge FundsIn this piece, we will take a look at the 12 most promising gene editing stocks according to hedge funds. If you want to skip our take on how the gene editing industry sits right at the top of the global innovation food chain, then you can take a look at the 5 Most Promising […] |
Investors in Pacific Biosciences of California (NASDAQ:PACB) have unfortunately lost 60% over the last three yearsPacific Biosciences of California, Inc. ( NASDAQ:PACB ) shareholders should be happy to see the share price up 29% in... |
PacBio Announces the Retirement of David Botstein, Ph.D., from its Board of DirectorsPacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that David Botstein, Ph.D., a member of PacBio's Board of Directors, has retired from his position effective December 7, 2023. |
The 3 Best Cathie Wood Stocks to Buy in DecemberCathie Wood stocks had a great November and are well-positioned to keep performing well, given the favorable macro backdrop. |
12 Best Genomics Stocks To Buy NowIn this piece, we will take a look at the 12 best genomics stocks to buy now. If you want to skip our introduction to the genomics industry and all the latest trends, then take a look at 5 Best Genomics Stocks To Buy Now. If there’s one thing that can be said with certainty […] |
Shockwave Medical (SWAV) Down 1% Since Last Earnings Report: Can It Rebound?Shockwave Medical (SWAV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Why Is IQVIA (IQV) Up 12.4% Since Last Earnings Report?IQVIA (IQV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |